Adaptimmune Therapeutics plc - American Depositary Shares (NQ:ADAP)

0.1674 +0.0230 (+15.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 159,978,048
Open 0.1524
Bid (Size) 0.1672 (179)
Ask (Size) 0.1696 (200)
Prev. Close 0.1444
Today's Range 0.1510 - 0.1936
52wk Range 0.0403 - 1.010
Shares Outstanding 1,535,653,620
Dividend Yield N/A

Performance

YTD
-73.2%
-73.2%
1 Month
+174.4%
+174.4%
3 Month
-30.9%
-30.9%
6 Month
-39.5%
-39.5%
1 Year
-82.2%
-82.2%

More News

Read More

Frequently Asked Questions

Is Adaptimmune Therapeutics plc - American Depositary Shares publicly traded?
Yes, Adaptimmune Therapeutics plc - American Depositary Shares is publicly traded.
What exchange does Adaptimmune Therapeutics plc - American Depositary Shares trade on?
Adaptimmune Therapeutics plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Adaptimmune Therapeutics plc - American Depositary Shares?
The ticker symbol for Adaptimmune Therapeutics plc - American Depositary Shares is ADAP on the Nasdaq Stock Market
What is the current price of Adaptimmune Therapeutics plc - American Depositary Shares?
The current price of Adaptimmune Therapeutics plc - American Depositary Shares is 0.1674
When was Adaptimmune Therapeutics plc - American Depositary Shares last traded?
The last trade of Adaptimmune Therapeutics plc - American Depositary Shares was at 09/22/25 04:00 PM ET
What is the market capitalization of Adaptimmune Therapeutics plc - American Depositary Shares?
The market capitalization of Adaptimmune Therapeutics plc - American Depositary Shares is 257.07M
How many shares of Adaptimmune Therapeutics plc - American Depositary Shares are outstanding?
Adaptimmune Therapeutics plc - American Depositary Shares has 257M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.